SecSonar.com

Barinthus Biotherapeutics plc (BRNS)

Barinthus Biotherapeutics plc at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Barinthus Biotherapeutics plc (BRNS) is a Biotechnology company based in GB with a market capitalization of $27.9M. Free cash flow was negative at -$48M. This page tracks BRNS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

GB · 105 employees · IPO Apr 30, 2021

Valuation

Valuation & price

$0.68 · as of May 26, 2026 · -65.4% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.38

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$1.97$1.26$0.54Jul 25Dec 25Jul 26Jul 7, 25$0.93Jul 9, 25$1.06Jul 11, 25$1.00Jul 15, 25$1.02Jul 17, 25$1.53Jul 21, 25$1.97Jul 23, 25$1.91Jul 25, 25$1.79Jul 29, 25$1.53Jul 31, 25$1.48Aug 4, 25$1.29Aug 6, 25$1.31Aug 11, 25$1.14Aug 13, 25$1.26Aug 15, 25$1.24Aug 19, 25$1.10Aug 21, 25$1.19Aug 25, 25$1.20Aug 27, 25$1.14Aug 29, 25$1.12Sep 3, 25$1.27Sep 5, 25$1.24Sep 9, 25$1.15Sep 11, 25$1.13Sep 16, 25$1.05Sep 18, 25$1.11Sep 22, 25$1.11Sep 24, 25$1.18Sep 26, 25$1.22Sep 30, 25$1.25Oct 2, 25$1.42Oct 6, 25$1.57Oct 8, 25$1.51Oct 10, 25$1.36Oct 14, 25$1.36Oct 16, 25$1.35Oct 21, 25$1.39Oct 23, 25$1.29Oct 27, 25$1.27Oct 29, 25$1.33Oct 31, 25$1.32Nov 4, 25$1.16Nov 6, 25$1.19Nov 10, 25$0.88Nov 12, 25$0.81Nov 14, 25$0.80Nov 18, 25$0.71Nov 20, 25$0.70Nov 25, 25$0.71Nov 28, 25$0.79Dec 2, 25$0.72Dec 4, 25$0.72Dec 8, 25$0.70Dec 10, 25$0.70Dec 12, 25$0.68Dec 16, 25$0.74Dec 18, 25$0.73Dec 22, 25$0.72Dec 24, 25$0.70Dec 29, 25$0.69Jan 2, 26$0.73Jan 6, 26$0.71Jan 8, 26$0.76Jan 12, 26$0.76Jan 14, 26$0.75Jan 16, 26$0.73Jan 21, 26$0.71Jan 23, 26$0.72Jan 27, 26$0.74Jan 29, 26$0.72Feb 2, 26$0.72Feb 4, 26$0.70Feb 9, 26$0.71Feb 11, 26$0.66Feb 13, 26$0.63Feb 18, 26$0.66Feb 20, 26$0.63Feb 24, 26$0.60Feb 26, 26$0.58Mar 2, 26$0.61Mar 4, 26$0.60Mar 6, 26$0.60Mar 10, 26$0.56Mar 12, 26$0.60Mar 17, 26$0.68Mar 19, 26$0.63Mar 23, 26$0.61Mar 25, 26$0.55Mar 27, 26$0.55Mar 31, 26$0.57Apr 2, 26$0.60Apr 7, 26$0.54Apr 9, 26$0.55Apr 13, 26$0.55Apr 15, 26$0.59Apr 17, 26$0.59Apr 22, 26$0.63Apr 24, 26$0.64Apr 28, 26$0.61Apr 30, 26$0.65May 4, 26$0.64May 6, 26$0.66May 8, 26$0.67May 12, 26$0.70May 14, 26$0.71May 18, 26$0.64May 20, 26$0.69May 22, 26$0.69May 28, 26$0.68Jun 1, 26$0.68Jun 3, 26$0.70Jun 5, 26$0.65Jun 9, 26$0.72Jun 11, 26$0.72Jun 15, 26$0.70Jun 17, 26$0.70Jun 22, 26$0.70Jun 24, 26$0.66Jun 26, 26$0.70Jul 2, 26$0.61
$0.5452-week range$1.97
Loading valuation history…

Fundamentals

Key fundamentals

$27.9M

Market cap

—

Revenue growth (YoY)

100.0%

Gross margin

-$48M

Free cash flow (USD)

-$59.2M

Net debt

Net cash position

3.0%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$6.8MFY 2020$4.8MFY 2021$268.0KFY 2022$44.7MFY 2023$802.0KFY 2024$15.0MFY 2025$0.00
$6.8M$0

Free cash flow by year

2019 → 2025

FY 2019$-18.9MFY 2020$-11.3MFY 2021$-33.7MFY 2022$-20.6MFY 2023$-56.3MFY 2024$-29.8MFY 2025$-48.0M
-$18.9M-$48M

Gross margin by year

2021 → 2024

FY 2021100.0%FY 2022100.0%FY 2023100.0%FY 2024100.0%
100.0%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 30, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJul 2, 2026Filing
  • 8-K eventScheme of Arrangement ApprovedMay 21, 2026Filing
  • 8-K eventCFO AppointmentApr 30, 2026Filing
  • Quarterly report10-Q FiledApr 30, 2026Filing
  • 8-K eventCFO AppointmentApr 22, 2026Filing
  • 8-K eventPrincipal Accounting Officer DepartureMar 31, 2026Filing

Questions

Frequently asked questions

What is Barinthus Biotherapeutics plc's market cap?

Barinthus Biotherapeutics plc (BRNS) has a market capitalization of $27.9M.

What is BRNS's P/E ratio?

A meaningful P/E ratio is not available for BRNS — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is BRNS's price-to-book (P/B) ratio?

BRNS trades at 0.38 times book value per share.

Are insiders buying BRNS stock?

SEC Form 4 filings show no open-market insider buys at Barinthus Biotherapeutics plc in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

DYAI

Dyadic International, Inc.

$27.9M

IGC

IGC Pharma, Inc.

$28.7M

LSTA

Lisata Therapeutics, Inc.

$28.8M

ALLR

Allarity Therapeutics, Inc.

$26M

EVAX

Evaxion Biotech A/S

$25.8M

OTLK

Outlook Therapeutics, Inc.

$30M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.